7:
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.
Satthaporn S, Aloysius MM, Robins RA, Verma C, Chuthapisith S, McKechnie AJ, El-Sheemy M, Vassanasiri W, Valerio D, Clark D, Jibril JA, Eremin O.
BMC Immunol. 2008 Jun 27;9:32.
PMID: 18588665 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
15:
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH.
Clin Cancer Res. 2003 Apr;9(4):1517-27.
PMID: 12684428 [PubMed - indexed for MEDLINE]
Related Articles
16:
A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro.
Yano Y, Ueda Y, Itoh T, Fuji N, Okugawa K, Naito K, Imura K, Kohara J, Hayashi T, Nakane K, Matsuura Y, Kawai K, Yamagishi H.
Oncol Rep. 2006 Jul;16(1):147-52.
PMID: 16786138 [PubMed - indexed for MEDLINE]
Related Articles
18:
Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K, Ueda Y, Itoh T, Fuji N, Shimizu K, Yano Y, Yamamoto Y, Imura K, Kohara J, Iwamoto A, Shiozaki A, Tamai H, Shimizu T, Mazda O, Yamagishi H.
Int J Oncol. 2006 Jun;28(6):1481-9.
PMID: 16685449 [PubMed - indexed for MEDLINE]
Related Articles